搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli L-ribulose-5-phosphate 3-epimerase UlaE (ulaE) CSB-YP334542ENV
CSB-EP334542ENV
CSB-BP334542ENV
CSB-MP334542ENV
CSB-EP334542ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Inner membrane protein ytfF (ytfF), partial CSB-YP334543ENV
CSB-EP334543ENV
CSB-BP334543ENV
CSB-MP334543ENV
CSB-EP334543ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein ytfI (ytfI) CSB-YP334544ENV
CSB-EP334544ENV
CSB-BP334544ENV
CSB-MP334544ENV
CSB-EP334544ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized HTH-type transcriptional regulator yjgJ (yjgJ) CSB-YP334545ENV
CSB-EP334545ENV
CSB-BP334545ENV
CSB-MP334545ENV
CSB-EP334545ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Gnt-II system L-idonate transporter (idnT), partial CSB-YP334546ENV
CSB-EP334546ENV
CSB-BP334546ENV
CSB-MP334546ENV
CSB-EP334546ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative uncharacterized protein yjhE (yjhE), partial CSB-YP334547ENV1
CSB-EP334547ENV1
CSB-BP334547ENV1
CSB-MP334547ENV1
CSB-EP334547ENV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized HTH-type transcriptional regulator yjhI (yjhI) CSB-YP334548ENV
CSB-EP334548ENV
CSB-BP334548ENV
CSB-MP334548ENV
CSB-EP334548ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative permease IIC component (sgcC), partial CSB-YP334549ENV
CSB-EP334549ENV
CSB-BP334549ENV
CSB-MP334549ENV
CSB-EP334549ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized N-acetyltransferase YjhQ (yjhQ) CSB-YP334550ENV
CSB-EP334550ENV
CSB-BP334550ENV
CSB-MP334550ENV
CSB-EP334550ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Probable 9-O-acetyl-N-acetylneuraminic acid deacetylase (nanS) CSB-YP334551ENV
CSB-EP334551ENV
CSB-BP334551ENV
CSB-MP334551ENV
CSB-EP334551ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Isoaspartyl dipeptidase (iadA) CSB-YP334552ENV
CSB-EP334552ENV
CSB-BP334552ENV
CSB-MP334552ENV
CSB-EP334552ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Uncharacterized protein yjiM (yjiM) CSB-YP334553ENV
CSB-EP334553ENV
CSB-BP334553ENV
CSB-MP334553ENV
CSB-EP334553ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative uncharacterized protein yjiP (yjiP) CSB-YP334554ENV
CSB-EP334554ENV
CSB-BP334554ENV
CSB-MP334554ENV
CSB-EP334554ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative uncharacterized protein yjiV (yjiV), partial CSB-YP334555ENV
CSB-EP334555ENV
CSB-BP334555ENV
CSB-MP334555ENV
CSB-EP334555ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative L-galactonate oxidoreductase (yjjN) CSB-YP334556ENV
CSB-EP334556ENV
CSB-BP334556ENV
CSB-MP334556ENV
CSB-EP334556ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Ribosomal RNA small subunit methyltransferase C (rsmC) CSB-YP334557ENV
CSB-EP334557ENV
CSB-BP334557ENV
CSB-MP334557ENV
CSB-EP334557ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli Putative kinase YjjJ (yjjJ) CSB-YP334558ENV
CSB-EP334558ENV
CSB-BP334558ENV
CSB-MP334558ENV
CSB-EP334558ENV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage T4 Uncharacterized 19.7 kDa protein in motB-dexA intergenic region (y00F) CSB-YP334559EDZ
CSB-EP334559EDZ
CSB-BP334559EDZ
CSB-MP334559EDZ
CSB-EP334559EDZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterobacteria phage T4 NAD--protein ADP-ribosyltransferase modB (modB) CSB-YP334560EDZ
CSB-EP334560EDZ
CSB-BP334560EDZ
CSB-MP334560EDZ
CSB-EP334560EDZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Natronomonas pharaonis Halocyanin (hcy) CSB-YP334561NAX
CSB-EP334561NAX
CSB-BP334561NAX
CSB-MP334561NAX
CSB-EP334561NAX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>